Bessemer Group’s KalVista Pharmaceuticals KALV Stock Holding History

Bessemer Group’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10	Closed	–	–	2588
2026 Q1	$0	Hold	10	–	–	﹤0.01%	2606
2025 Q4	$0	Hold	10	–	–	﹤0.01%	2627
2025 Q3	$0	Buy	+10	New	+$138	﹤0.01%	2609
2024 Q4	–	Sell	-45	Closed	-$1K	–	2570
2024 Q3	$1K	Buy	+45	New	+$566	﹤0.01%	2447

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bessemer Group's KALV Position: Q2 2026 in Review

Bessemer Group sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 10 shares.

Bessemer Group first reported a position in KALV in Q3 2024 and held it in 4 quarters. The position peaked at $1K in Q3 2024. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Bessemer Group reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Bessemer Group sold 10 KalVista Pharmaceuticals shares in Q2 2026.
Bessemer Group first reported a position in KalVista Pharmaceuticals in Q3 2024 and held it in 4 quarters.
Bessemer Group's KalVista Pharmaceuticals position peaked at $1K in Q3 2024.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.